Anti-FcεRIα autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship

Journal of Clinical Investigation

Volumn 101, Issue 1, 1998, Pages 243-251

  Fiebiger, Edda ^a   Hammerschmid, Franz ^b   Stingl, Georg ^a   Maurer, Dieter ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b NOVARTIS RESEARCH INSTITUTE   (Austria)

Author keywords

Autoimmunity; Chronic urticaria; Complement activation; Histamine release; IgE receptors

Indexed keywords

AUTOANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; LEUKOCYTE ANTIGEN; RECOMBINANT PROTEIN;

ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHRONIC URTICARIA; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DERMATOMYOSITIS; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SYSTEMIC LUPUS ERYTHEMATOSUS; AUTOIMMUNE DISEASE; BASOPHIL; BLOOD; CHRONIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METHODOLOGY; SECRETION; SOLUBILITY; URTICARIA;

ANTIGENS, CD; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BASOPHILS; CHRONIC DISEASE; COMPLEMENT C5A; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RECEPTORS, IGE; RECOMBINANT PROTEINS; SOLUBILITY; URTICARIA;

EID: 0031595112     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI511     Document Type: Article

References (34)

1. Kaplan, A.P. 1983. Chronic urticaria. Possible causes, suggested treatment alternatives. Postgrad. Med. 74:209-215.
2. Hide, M., D.M. Francis, C.E.H. Grattan, J. Hakimi, J.P. Kochan, and M.W. Greaves. 1993. Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N. Engl. J. Med. 328:1599-1604.
3. Fiebiger, E., D. Maurer, H. Holub, B. Reininger, G. Hartmann, M. Woisetschläger, J.-P. Kinet, and G. Stingl. 1995. Serum IgG autoantibodies directed against the α chain of Fc∈RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J. Clin. Invest. 96:2606-2612.
4. Fiebiger, E., G. Stingl, and D. Maurer. 1996. Anti-IgE and anti-Fc∈RI autoantibodies in clinical allergy. Curr. Opin. Immunol. 8:784-789.
5. Tong, L.J., G. Balakrihan, J.P. Kochan, J.-P. Kinet, and A.P. Kaplan. 1997. Assessment of autoimmunity in patients with chronic urticaria. J. Allergy Clin. Immunol. 99:461-465.
6. Niimi, N., D.M. Francis, F. Kermani, B.F. O'Donnell, M. Hide, A. Kobaza-Black, R.K. Winkelmann, M.W. Greaves, and R.M. Barr. 1996. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J. Investig. Dermatol. 106:1001-1006.
7. Huston, D.P., and R.B. Bressler. 1992. Urticaria and angioedema. Med. Clin. North. Am. 76:805-840.
8. Stadler, B.M. 1993. Biological activities of anti-IgE antibodies. Int. Arch. Allergy Immunol. 102:121-126.
9. Kirnbauer, R. 1996. Papillomavirus-like particles for serology and vaccine development. Intervirology. 39:54-61.
10. Wang, B., A. Rieger, O. Kilgus, K. Ochiai, D. Maurer, D. Födinger, J.-P. Kinet, and G. Stingl. 1992. Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc∈RI. J. Exp. Med. 175:1353-1365.
11. Inganas, M., S.G.O. Johansson, and H. Bennich. 1981. Anti-IgE antibodies in human serum: occurrence and specificity. Int. Arch. Allergy Appl. Immunol. 65:51-61.
12. Grattan, C.E.H., D.M. Francis, M. Hide, and M.W. Greaves. 1991. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin. Exp. Allergy. 21:695-704.
13. Liszewski, M.K., T.C. Farries, D.M. Lublin, I.A. Rooney, and J.P. Atkinson. 1996. Control of the complement system. Adv. Immunol. 61:201-283.
14. desarg retains basophil-activating properties. Eur. J. Immunol. 24:1583-1589.
15. Giannini, E., and F. Boulay. 1995. Phosphorylation, dephosphorylation and recycling of the C5a receptor in differentiated HL60 cells. J. Immunol. 154: 4055-4064.
16. Gerard, C., and N.P. Gerard. 1994. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775-808.
17. Naito, K., M. Hirama, K. Okumura, and C. Ra. 1995. Soluble form of the human high-affinity receptor for IgE inhibits recurrent allergic reaction in a novel mouse model of type I allergy. Eur. J. Immunol. 25:1631-1637.
18. Saban, R., M. Haak-Frendscho, M. Zine, J. Ridgway, C. Gorman, L. Presta, D. Bjorling, M. Saban, and P. Jardieu. 1994. Human Fc∈RI-IgG and humanized anti-IgE monoclonal antibody MaE11 block passive sensitization of human and rhesus monkey lung. J. Allergy Clin. Immunol. 94:836-843.
19. Gavin, A.L., J. Snider, M.D. Hulett, I.F. Mckenzie, and P.M. Hogarth. 1995. Expression of soluble Fc∈RI: function and tissue distribution studies. Immunology. 86:392-398.
20. Grattan, C.E.H., D.M. Francis, N.G.P. Slater, R.J. Barlow, and M.W. Greaves. 1992. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet. 339:1078-1080.
21. Boros, P., J.A. Odin, J. Chen, and J.C. Unkeless. 1994. Specific and class distribution of FcγR-specific autoantibodies in patients with autoimmune disease. J. Immunol. 152:302-306.
22. Miletic, V.D., and M.M. Frank. 1995. Complement-immunoglobulin interactions. Curr. Opin. Immunol. 7:41-17.
23. Coffman, R.L., D.A. Lebman, and P. Rothman. 1993. The mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54:229-263.
24. Metzger, H. 1991. The high affinity receptor for IgE on mast cells. Clin. Exp. Allergy. 21:269-279.
25. Ravetch, J.V., and J.-P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9:457-492.
26. Goldstein, I.M. 1992. Complement. In Inflammation: Basic Principles and Clinical Correlates. J.I. Gallin, I.M. Goldstein, and R. Snyderman, editors. Raven Press, Ltd., New York. 63-80.
27. Huizinga, T.W.J., C.E. van der Schoot, C. Jost, R. Klaassen, M. Kleijer, A.E.G.K. von dem Borne, D. Roos, and P.A.T. Tetteroo. 1988. The PI-linked receptor FcRIII is released on stimulation of neutrophils. Nature. 333:667-669.
28. Sautes, C., N. Varin, C. Teillaud, M. Daeron, J. Even, P.M. Hogarth, and W.H. Fridman. 1991. Soluble Fcγ receptors II (FcγRII) are generated by cleavage of membrane FcγRII. Eur. J. Immunol. 21:231-234.
29. Astier, A., H. de la Salle, J. Moncuit, M. Freund, J.-P. Cazenave, W.-H. Fridman, D. Hanau, and J.-L. Teillaud. 1993. Detection and quantification of secreted soluble FcγRIIA in human sera by an enzyme-linked immunosorbent assay. J. Immunol. Methods. 166:1-10.
30. Armant, M., H. Ishihara, M. Rubio, G. Delespesse, and M. Sarfati. 1994. Regulation of cytokine production by soluble CD23: costimulation of interferon γ secretion and triggering of tumor necrosis α release. J. Exp. Med. 180: 1005-1011.
31. Kalimo, K., and C.T. Jansen. 1980. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine). Ann. Allergy. 44:34-37.
32. Werfel, T., M. Oppermann, G. Begemann, O. Götze, and J. Zwirner. 1997. C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry. Arch. Dermatol. Res. 289:83-86.
33. Füreder, W., H. Agis, M. Willheim, H.C. Bankl, U. Maier, K. Kishi, M.R. Müller, K. Czerwenka, T. Radaszkiewicz, J.H. Butterfield, et al. 1995. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 155:3152-3160.
34. Bischoff, S.C., S. Schwengberg, K. Wordelmann, A. Weimann, R. Raab, and M.P. Manns. 1996. Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. Gut. 38:104-114.